Abstract
The authors investigated the effect of oxcarbazepine on cognitive function in children and adolescents (6 to younger than 17 years of age) with newly diagnosed partial seizures in an open-label comparison with standard antiepileptic drug therapy (carbamazepine and valproate). No differences in cognitive tests were observed between oxcarbazepine and carbamazepine/valproate over a 6-month treatment period.
Original language | English |
---|---|
Pages (from-to) | 679-682 |
Number of pages | 4 |
Journal | Neurology |
Volume | 67 |
Issue number | 4 |
DOIs | |
Publication status | Published - Aug 2006 |
ASJC Scopus subject areas
- Neuroscience(all)